Skip to main navigation

English
Français

IR Navigation

Overview
News
Events & Presentations
- Events
- Presentations
Stock Information
Financials
Governance
Resources

Press Releases

Press Releases

Items Per Page

Year

23 Apr 2021

GENFIT: Publication of the 2020 Universal Registration Document and the 2020 Annual Report on Form 20-F; Annual Shareholders Meeting to take place on June 15, 2021

22 Apr 2021

GENFIT hires Thomas Baetz as Chief Financial Officer and adds two new members to its Executive Committee

01 Apr 2021

GENFIT Reports Full-Year 2020 Financial Results and Provides Corporate Update

04 Mar 2021

GENFIT appoints Jean-François Tiné to the Board of Directors

26 Feb 2021

GENFIT: Revenues and Cash Position as of December 31, 2020

22 Feb 2021

GENFIT: new market research data highlight potential of elafibranor in PBC

10 Feb 2021

GENFIT: 2021 Financial Calendar

09 Feb 2021

GENFIT Announces Publication of Positive Results from the Phase 2 Clinical Trial Evaluating Elafibranor in Patients with PBC in the Journal of Hepatology

28 Jan 2021

GENFIT Announces Two Key Appointments to the Executive Committee

27 Jan 2021

GENFIT: Technical Corrections to the Results of the January 25, 2021 Bondholders Meeting with No Impact on Resolutions’ Approval

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 26

Shareholder Tools

Print Page
Email Alerts
RSS
Contact IR

Request E-mail Alerts

GENFIT Headquarters
Parc Eurasanté 885, Avenue Eugène Avinée 59120 Loos France GENFIT Corp
1 Alewife Center Suite 220 Cambridge MA 02140 USA

All rights reserved.